Table 1

Clinical data of patients
Sample name Gender/ Age Disease duration RF ESR (mm/h) CRP (mg/ml) ARA criteria Concurrent medication
Rheumatoid Arthritis
EB87 F/65 12 + 50,00 106,7 5 NSAIDs
EB88 F/62 10 + 90,00 169,5 6 NSAIDs
EB213 F/69 15 + 94,00 99,1 4 NSAIDs, Leflunomide, Prednis
EB220 F/57 20 + 23,00 2,3 4 NSAID, MTX, Prednis.
EB221 F/66 12 + 7,00 5,4 4 Lantarel, MTX
EB227 F/49 25 + 12,00 2,4 5 NSAIDs, MTX, Prednis.
Osteoarthritis
EB168 F/68 20 - 18,00 20,3 0 NSAIDs
EB173 F/81 2,5 - 38,00 32,0 2 NSAIDs, Prednis.
EB190 M/56 5 - 6,00 0,5 1 NSAIDs
EB194 F/79 8 - 28,00 0,3 1 NSAIDs
EB202 M/65 5 - 7,00 3,0 0 NSAIDs
EB205 F/55 3 - 47,00 36,0 0 NSAIDs

ARA, American Rheumatism Association (now American College of Rheumatology); CRP, C-reactive protein (normal range <5 mg/l); ESR, erythrocyte sedimentation rate; F, female; M, male; MTX, methotrexate; NSAIDs, non steroidal anti-inflammatory drugs; RF, rheumatoid factor;-,negative; +, positive.

Kupfer et al.

Kupfer et al. BMC Medical Genomics 2012 5:23   doi:10.1186/1755-8794-5-23

Open Data